Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yaroslav S. Enin"'
Autor:
Sofia V. Timofeeva, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Inna A. Novikova, Elena Yu Zlatnik, Yaroslav S. Enin, Oleg N. Burov, Dmitry A. Kharagezov, Oleg N. Stateshny, Anton G. Milakin, Igor A. Leyman, Ellada A. Mirzoyan, Madina A. Gappoeva, Victoria N. Vitkovskaya, Kristian D. Iozefi, Yuriy N. Lazutin
Publikováno v:
Journal of Clinical Oncology. 40:e15079-e15079
e15079 Background: Initially, berberine was used as an antimicrobial agent in traditional medicine, but its anticancer properties were later discovered. In addition to its cytotoxic effect, berberine also has the ability to inhibit cell motility, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a714df0b2d2a4d9095a54d6f9147d24b
https://doi.org/10.1200/jco.2022.40.16_suppl.e15079
https://doi.org/10.1200/jco.2022.40.16_suppl.e15079
Autor:
Irina V. Mezhevova, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Yaroslav S. Enin, Oleg N. Burov, Elena Yu Zlatnik, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Sergey V. Tumanyan, Nina M. Abdullaeva, Anna A. Cherkasova, Polina A. Kruze, Meri L. Adamyan
Publikováno v:
Journal of Clinical Oncology. 40:e15078-e15078
e15078 Background: It is known that berberine inhibits oxidative phosphorylation by suppressing respiratory complex I function, but the exact mechanism of this phenomenon has not yet been described. The aim of the study was to evaluate the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee1c77c94423b0dd50143519b4cf5f7e
https://doi.org/10.1200/jco.2022.40.16_suppl.e15078
https://doi.org/10.1200/jco.2022.40.16_suppl.e15078
Autor:
Sofia V. Timofeeva, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Inna A. Novikova, Yaroslav S. Enin, Oleg N. Burov, Elena Yu Zlatnik, Anna P. Menshenina, Tatiana I. Moiseenko, Ekaterina V. Verenikina, Oksana E. Zhenilo, Yuriy A. Poryvaev, Tatiana Yu. Myagkova, Viktoria V. Pozdnyakova, Meri L. Adamyan
Publikováno v:
Journal of Clinical Oncology. 40:e15077-e15077
e15077 Background: Plant metabolites are traditionally a valuable source of anticancer drugs. The huge variety of molecular structures found in plants makes it possible to isolate substances that possess not only antimitotic, but also anti-migratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e5f440dc73f97806b39210cae8f925c
https://doi.org/10.1200/jco.2022.40.16_suppl.e15077
https://doi.org/10.1200/jco.2022.40.16_suppl.e15077
Autor:
Irina V. Mezhevova, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Elena Yu Zlatnik, Yaroslav S. Enin, Oleg N. Burov, Dmitry A. Kharagezov, Oleg N. Stateshny, Anton G. Milakin, Igor A. Leyman, Ellada A. Mirzoyan, Madina A. Gappoeva, Yuriy N. Lazutin, Victoria N. Vitkovskaya, Kristian D. Iozefi
Publikováno v:
Journal of Clinical Oncology. 40:e15097-e15097
e15097 Background: The energy metabolism of tumor cells and infiltrating stromal cells is a promising target in anticancer therapy. One of the mechanisms of antitumor activity of berberine is its ability to suppress oxidative phosphorylation in cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41ae49d397481352492191ff3b56cb97
https://doi.org/10.1200/jco.2022.40.16_suppl.e15097
https://doi.org/10.1200/jco.2022.40.16_suppl.e15097
Autor:
Irina L. Popova, Faina V. Alieva, Aza A. Agieva, Oleg N. Burov, Yaroslav S. Enin, Natalia M. Tikhanovskaya, Marina M. Sergeeva, Valeriya S Myagkova, Liubov Yu Vladimirova, Ludmila A. Ryadinskaya, Natalia A. Abramova, Maria A. Teplyakova, Elena Yu. Zlatnik, Kristina A. Novoselova
Publikováno v:
Journal of Clinical Oncology. 39:e15063-e15063
e15063 Background: The study of the possible antitumor activity of secondary plant metabolites either in the form of individual agents or in combination with clinically used drugs is considered as a promising direction in the therapy of malignant tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::730594e5f95625fc1110df34b6ac6d52
https://doi.org/10.1200/jco.2021.39.15_suppl.e15063
https://doi.org/10.1200/jco.2021.39.15_suppl.e15063
Autor:
Inna Arnoldovna Novikova, Svetlana Yu. Filippova, Oleg I. Kit, Anastasia O. Sitkovskaya, Stanislav Stanislavovich Mezentsev, Tatiana V. Shamova, Olga V. Khokhlova, Sofia V. Timofeeva, Tatiana F. Pushkareva, Oleg N. Burov, Yaroslav S. Enin, Viktoria V. Pozdnyakova, Irina V. Mezhevova
Publikováno v:
Journal of Clinical Oncology. 39:e15045-e15045
e15045 Background: Berberine is an alkaloid compound with a structure that is highly similar to that of intercalating agents. It affects numerous cell signaling pathways and is widely studied as potential anticancer drug. It is known that berberine a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d27e797685755638946bdb092dcd77f3
https://doi.org/10.1200/jco.2021.39.15_suppl.e15045
https://doi.org/10.1200/jco.2021.39.15_suppl.e15045
Autor:
Oleg I, Kit, Dmitry I, Vodolazhsky, Natalia N, Timoshkina, Lubov' Yu, Vladimirova, Igor N, Turkin, Ksenia A, Kutsyn, Yaroslav S, Enin, Svetlana B, Panina, Vladimir, Jurisic
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 22(6)
To assess the frequencies of somatic EGFR mutations in the tumor tissues of patients with non-small cell lung cancer (NSCLC) residing in the South of Russia (SR), and to define the relationship between genetic subtypes of NSCLC and the emergence of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f80cc1c69b80d387dcf76681be52ebd0
https://pubmed.ncbi.nlm.nih.gov/29332331
https://pubmed.ncbi.nlm.nih.gov/29332331
Autor:
Denis S. Kutilin, Peter V. Zolotukhin, Yaroslav S. Enin, Yury A. Gevorkyan, Yanis Boumber, Oleg I. Kit, S. B. Panina, Leonid V. Kharin, Dmitry I. Vodolazhsky
Publikováno v:
The protein journal. 36(6)
Colorectal cancer is the second most common cancer in women and third most common cancer in men. Cell signaling alterations in colon cancer, especially in aggressive metastatic tumors, require further investigations. The present study aims to compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf7c0850d2857f5774123cd5979d4a3
https://pubmed.ncbi.nlm.nih.gov/29128960
https://pubmed.ncbi.nlm.nih.gov/29128960
Autor:
Oleg I. Kit, Aza A. Lyanova, Natalya N. Timoshkina, Irina V. Aedinova, Natalia A. Chertova, Mamuka V. Bauzhadze, Liubov Yu Vladimirova, Yaroslav S. Enin, Marina A. Engibaryan, Viktoriya L. Volkova
Publikováno v:
Journal of Clinical Oncology. 37:e17524-e17524
e17524 Background: Mutations in KRAS are known to be predictors of anti-EGFR therapy efficacy. Besides the mutation status of the treatment-naive tumors the changes in the level of mutant DNA during medical treatment are also of clinical interest for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0aeaf1c98481e481c687aee12f0aed6
https://doi.org/10.1200/jco.2019.37.15_suppl.e17524
https://doi.org/10.1200/jco.2019.37.15_suppl.e17524
Autor:
Andrey V. Dashkov, Anton G. Milakin, Natalya V. Soldatkina, Yuriy A. Gevorkyan, Dmitry A. Kharagezov, Yaroslav S. Enin, Vyacheslav A. Sustretov, Liubov Yu Vladimirova, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 37:e15080-e15080
e15080 Background: The screening of mutations in the KRAS gene is a traditional marker of the effectiveness of targeted therapy for colorectal cancer. Mutations in the 12 codon of the second exon of the KRAS gene are present in 40% of colorectal tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf4d6a62645404bd6422a2bbda5ea7c3
https://doi.org/10.1200/jco.2019.37.15_suppl.e15080
https://doi.org/10.1200/jco.2019.37.15_suppl.e15080